Meryl C. Nath
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Meryl C. Nath has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Jessica Schmitt
Department of Pediatrics, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, United States
2 shared publications - Joycelyn Atchison
Department of Pediatrics University of Alabama at Birmingham Heersink School of Medicine Birmingham Alabama USA
2 shared publications - Anupam Agarwal
University of Alabama at Birmingham
1 shared publication - Blake Frey
Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35203, USA
1 shared publication - Joshua S. Richman
Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama
1 shared publication
Latest Publications
- Open Access
- 12 September 2024
- Published by Wiley in Journal of Diabetes
- Vol. 16 (9) , e13602
Continuous glucose monitor metrics and hemoglobin A1c correlation in youth with diabetes: A retrospective analysis of real‐world correlations
- 12 September 2024
- Published by Wiley in Journal of Diabetes
- Vol. 16 (9) , e13602
Open AccessContinuous glucose monitor metrics and hemoglobin A1c correlation in youth with diabetes: A retrospective analysis of real‐world correlations
- Open Access
- 25 October 2023
- Published by Wiley in Pediatric Diabetes
- Vol. 2023, 1-6
Disparities in Glycemic Outcomes Persist in Youth with Type 1 Diabetes and High-Technology Use
Background. Racial disparities are well described in glycemic outcomes in youth with Type 1 diabetes mellites (T1D). Hemoglobin A1c (HbA1c) has some limitations in comparing glycemia across patient groups as there are individual variations in mean glucose and HbA1c. Objective. This study aimed to compare glycemic metrics obtained from (Dexcom G6) continuous glucose monitor (CGM) device with HbA1c levels controlling for race, age, duration of diabetes, race, insurance status, and insulin pump use with glycemic control. Subjects and Methods. Data analyzed included 188 patients, majority non-Hispanic White (NHW) (n = 147, 78.2%) and majority privately insured (n = 147, 78.2%). Half of the patients were using insulin pumps, (n = 94, 50.0%) and approximately half were female. Median age was 16.6 (interquartile range: 14.2–18.2) years old with a median age of diabetes diagnosis at 9.3-years old. Results. Significant differences were observed between NHW and non-Hispanic Black (NHB) patients in terms of HbA1c, 90-day mean glucose, and 90-day time >250 mg/dL (>13.9 mmol/L) (7.6% vs. 9.2%, 181 mg/dL vs. 220 mg/dL, and 16.3% vs. 34.7%, respectively, for all comparisons). Multiple linear regression analysis was performed to predict the influence of age, duration of diabetes, race, insurance status, and insulin administration on glycemic outcomes. Regression analysis revealed significant equations for all glycemic outcomes, demonstrating a strong correlation ( , , and , respectively). However, after controlling for these variables, only race and duration of diabetes remained independently associated with glycemic outcomes, suggesting that these factors strongly influence glycemic control independent of age, sex, insurance, and pump use. Conclusion. Even in a subset of youth with T1D using CGM with high rates of insulin pump use, disparities in glycemic outcomes persist. When evaluating glycemic outcomes, race remained a significant cofactor despite controlling for age, duration of diabetes, sex, insurance status, and insulin administration type. These results add to the existing literature, and demonstrate race remains strong predictor of glycemic outcomes.
- 25 October 2023
- Published by Wiley in Pediatric Diabetes
- Vol. 2023, 1-6
Open AccessDisparities in Glycemic Outcomes Persist in Youth with Type 1 Diabetes and High-Technology Use
Background. Racial disparities are well described in glycemic outcomes in youth with Type 1 diabetes mellites (T1D). Hemoglobin A1c (HbA1c) has some limitations in comparing glycemia across patient groups as there are individual variations in mean glucose and HbA1c. Objective. This study aimed to compare glycemic metrics obtained from (Dexcom G6) continuous glucose monitor (CGM) device with HbA1c levels controlling for race, age, duration of diabetes, race, insurance status, and insulin pump use with glycemic control. Subjects and Methods. Data analyzed included 188 patients, majority non-Hispanic White (NHW) (n = 147, 78.2%) and majority privately insured (n = 147, 78.2%). Half of the patients were using insulin pumps, (n = 94, 50.0%) and approximately half were female. Median age was 16.6 (interquartile range: 14.2–18.2) years old with a median age of diabetes diagnosis at 9.3-years old. Results. Significant differences were observed between NHW and non-Hispanic Black (NHB) patients in terms of HbA1c, 90-day mean glucose, and 90-day time >250 mg/dL (>13.9 mmol/L) (7.6% vs. 9.2%, 181 mg/dL vs. 220 mg/dL, and 16.3% vs. 34.7%, respectively, for all comparisons). Multiple linear regression analysis was performed to predict the influence of age, duration of diabetes, race, insurance status, and insulin administration on glycemic outcomes. Regression analysis revealed significant equations for all glycemic outcomes, demonstrating a strong correlation ( , , and , respectively). However, after controlling for these variables, only race and duration of diabetes remained independently associated with glycemic outcomes, suggesting that these factors strongly influence glycemic control independent of age, sex, insurance, and pump use. Conclusion. Even in a subset of youth with T1D using CGM with high rates of insulin pump use, disparities in glycemic outcomes persist. When evaluating glycemic outcomes, race remained a significant cofactor despite controlling for age, duration of diabetes, sex, insurance status, and insulin administration type. These results add to the existing literature, and demonstrate race remains strong predictor of glycemic outcomes.
- Open Access
- 31 December 2020
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 39 (4) , 387-401
New insights into the role of heme oxygenase-1 in acute kidney injury
Meryl Nath, Anupam Agarwal. Kidney Research and Clinical Practice 2020;39:387-401. https://doi.org/10.23876/j.krcp.20.091
- 31 December 2020
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
- Vol. 39 (4) , 387-401
Open AccessNew insights into the role of heme oxygenase-1 in acute kidney injury
Meryl Nath, Anupam Agarwal. Kidney Research and Clinical Practice 2020;39:387-401. https://doi.org/10.23876/j.krcp.20.091